Does a cannabis license automatically transfer when I buy a cannabis business?

No. Most states require regulator approval of ownership changes before a license transfers. Closing a deal without completing the change-of-ownership process can void the license. Timelines range from 30 days to 18+ months depending on the state and license type.

What is the biggest hidden liability in cannabis M&A?

280E tax liability is frequently the most significant hidden exposure. Sellers may have taken aggressive deductions that are vulnerable to IRS audit, or may have under-reported taxable income. A dedicated 280E review as part of diligence is non-negotiable on material transactions.

Can I use a cannabis license as collateral for acquisition financing?

Most states prohibit pledging cannabis licenses as collateral. Lenders have developed workarounds (equity pledges, springing liens on real property), but the enforceability of each structure is jurisdiction-specific. Confirm local law before structuring the financing.

Cannabis M&A Due Diligence | Hoban Law Group

Structured diligence frameworks for acquiring, merging with, or investing in licensed cannabis operators — covering license transferability, regulatory liabilities, and 280E exposure.

Why Cannabis M&A Is Different

Acquiring a cannabis business is not like acquiring any other regulated business. Every state imposes change-of-ownership (COO) notification or approval requirements, and licenses cannot transfer without regulator consent in most jurisdictions. Skipping regulatory diligence — or misreading a COO timeline — can invalidate the deal.

Core Diligence Workstreams

License Status and Transferability

Confirm all licenses are in active, compliant status with no pending revocations or suspensions
Map the exact COO process for each license type in each jurisdiction: notification vs. pre-approval, timelines, fee schedules, background check requirements for new principals
Identify any license conditions or restrictions that would survive acquisition

Regulatory Violation History

Pull full compliance histories from the applicable state regulator — not just what the seller discloses
Review inspection reports, notice-of-violation letters, and settlement agreements
Assess whether any outstanding violations could trigger license action during or after the deal

Seed-to-Sale Records and Track-and-Trace Gaps

Discrepancies between physical inventory and system-of-record (Metrc, BioTrackTHC) can constitute violations. Acquirers inherit those discrepancies on closing day.

280E Tax Liabilities

Section 280E of the Internal Revenue Code denies ordinary business deductions for businesses trafficking in Schedule I controlled substances. Pre-close, acquirers must assess:

Prior-year 280E compliance (or non-compliance) and open audit risk
Allocations between cannabis and non-cannabis cost-of-goods-sold
Whether the target has filed amended returns or taken aggressive positions likely to attract IRS scrutiny

Financing and Banking

Cannabis companies often carry non-traditional financing. Confirm whether security interests encumber licenses (which may be prohibited under state law) and whether lender consent is required for the transaction.

Structuring the Deal

Most cannabis M&A closes as asset purchases (to isolate pre-close liabilities) rather than stock acquisitions. Regulatory approval timelines should drive escrow and closing structures — do not set hard closing dates that cannot flex for regulator processing.

Hoban Law Group's Role

Robert Hoban's practice has advised on cannabis transactions in more than 20 U.S. states and multiple international jurisdictions. His team provides regulatory diligence memoranda, license transfer management, and transaction counsel from LOI through post-close compliance integration.

[Request a consultation about your cannabis acquisition](/consultation?source=insights&topic=cannabis-ma-due-diligence&matter_type=ma) to discuss diligence scope and timeline.

Cannabis M&A Due Diligence